Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India · Delayed Price · Currency is INR 1,133.20
-13.60 (-1.19%)
May 29, 2026, 3:30 PM IST
Tatva Chintan Pharma Chem Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 420.54 | 57.13 | 303.54 | 454.87 | 958.74 |
Depreciation & Amortization | 368.47 | 267.63 | 253.9 | 94 | 81.33 |
Other Amortization | - | 8.96 | 2.15 | 1.55 | 0.47 |
Loss (Gain) From Sale of Investments | -0.06 | -0.75 | -1.89 | - | - |
Other Operating Activities | 145.19 | -9.06 | 78.39 | -28.6 | -67.09 |
Change in Accounts Receivable | -215.03 | -151.62 | 153.85 | -280.75 | 322.99 |
Change in Inventory | -621.2 | 188.11 | 97.32 | 74.59 | -979.38 |
Change in Accounts Payable | 196.95 | -131.05 | 112.48 | -123.73 | -30.63 |
Change in Other Net Operating Assets | 20.03 | 17.36 | -19.3 | 85.9 | -84.13 |
Operating Cash Flow | 314.89 | 246.71 | 980.44 | 277.83 | 202.3 |
Operating Cash Flow Growth | 27.64% | -74.84% | 252.89% | 37.34% | 2.72% |
Capital Expenditures | -1,138 | -762.72 | -1,285 | -2,031 | -891.57 |
Sale of Property, Plant & Equipment | 3.58 | 1.39 | 1.55 | 0.68 | 0.78 |
Investment in Securities | -46.74 | 103.92 | 45.46 | 965.73 | -1,123 |
Other Investing Activities | 22.48 | 4.87 | 32.74 | 53.25 | 46.59 |
Investing Cash Flow | -1,158 | -652.54 | -1,205 | -1,011 | -1,967 |
Short-Term Debt Issued | 785.84 | 257.49 | - | 637.4 | 422.85 |
Long-Term Debt Issued | 60.4 | - | - | 8.29 | - |
Total Debt Issued | 846.24 | 257.49 | - | 645.69 | 422.85 |
Short-Term Debt Repaid | - | - | -1,462 | - | - |
Long-Term Debt Repaid | -6.38 | -32.19 | -85.89 | -139.26 | -133.83 |
Total Debt Repaid | -6.38 | -32.19 | -1,548 | -139.26 | -133.83 |
Net Debt Issued (Repaid) | 839.86 | 225.3 | -1,548 | 506.43 | 289.02 |
Issuance of Common Stock | - | - | 2,000 | - | 2,250 |
Common Dividends Paid | -23.39 | -46.78 | -46.78 | -44.33 | - |
Other Financing Activities | -27.15 | -12.86 | -100.06 | -84.15 | -188.91 |
Financing Cash Flow | 789.32 | 165.66 | 305.19 | 377.95 | 2,350 |
Foreign Exchange Rate Adjustments | -1.89 | 0.87 | -0.84 | -0.86 | -0.18 |
Net Cash Flow | -56.1 | -239.3 | 79.39 | -356.52 | 585.36 |
Free Cash Flow | -822.85 | -516.01 | -304.71 | -1,753 | -689.27 |
Free Cash Flow Margin | -16.27% | -13.48% | -7.74% | -41.39% | -15.90% |
Free Cash Flow Per Share | -35.18 | -22.06 | -13.31 | -79.10 | -32.06 |
Cash Interest Paid | 26.87 | 8.96 | 61.51 | 79.97 | 43.51 |
Cash Income Tax Paid | 76.79 | 44.98 | 85.62 | 92.9 | 184.07 |
Levered Free Cash Flow | -925.59 | -526.95 | -672.26 | -529.3 | -2,039 |
Unlevered Free Cash Flow | -907.77 | -521.35 | -633.82 | -479.32 | -2,012 |
Change in Working Capital | -619.25 | -77.2 | 344.35 | -243.99 | -771.15 |